Jim Simons Novartis Ag Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Novartis Ag stock. As of the latest transaction made, Renaissance Technologies LLC holds 2,940,582 shares of NVS stock, worth $302 Million. This represents 0.45% of its overall portfolio holdings.
Number of Shares
2,940,582
Previous 2,838,082
3.61%
Holding current value
$302 Million
Previous $287 Million
0.74%
% of portfolio
0.45%
Previous 0.44%
Shares
22 transactions
Others Institutions Holding NVS
# of Institutions
1,342Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.27 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.27 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$744 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$617 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$607 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $221B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...